Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploiting the mutanome for tumor vaccination.
Castle JC, Kreiter S, Diekmann J, Löwer M, van de Roemer N, de Graaf J, Selmi A, Diken M, Boegel S, Paret C, Koslowski M, Kuhn AN, Britten CM, Huber C, Türeci O, Sahin U. Castle JC, et al. Among authors: de graaf j, van de roemer n. Cancer Res. 2012 Mar 1;72(5):1081-91. doi: 10.1158/0008-5472.CAN-11-3722. Epub 2012 Jan 11. Cancer Res. 2012. PMID: 22237626 Free article.
Mutant MHC class II epitopes drive therapeutic immune responses to cancer.
Kreiter S, Vormehr M, van de Roemer N, Diken M, Löwer M, Diekmann J, Boegel S, Schrörs B, Vascotto F, Castle JC, Tadmor AD, Schoenberger SP, Huber C, Türeci Ö, Sahin U. Kreiter S, et al. Among authors: van de roemer n. Nature. 2015 Apr 30;520(7549):692-6. doi: 10.1038/nature14426. Epub 2015 Apr 22. Nature. 2015. PMID: 25901682 Free PMC article.
CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.
Diken M, Boegel S, Grunwitz C, Kranz LM, Reuter K, van de Roemer N, Vascotto F, Vormehr M, Kreiter S. Diken M, et al. Among authors: van de roemer n. Hum Vaccin Immunother. 2014;10(10):3090-100. doi: 10.4161/hv.29767. Hum Vaccin Immunother. 2014. PMID: 25483671 Free PMC article. No abstract available.
CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy.
Kranz LM, Birtel M, Krienke C, Grunwitz C, Petschenka J, Reuter KC, van de Roemer N, Vascotto F, Vormehr M, Kreiter S, Diken M. Kranz LM, et al. Among authors: van de roemer n. Hum Vaccin Immunother. 2016;12(1):213-21. doi: 10.1080/21645515.2015.1068485. Epub 2015 Jul 17. Hum Vaccin Immunother. 2016. PMID: 26186022 Free PMC article. No abstract available.
Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancer.
Kreiter S, Vormehr M, van de Roemer N, Diken M, Löwer M, Diekmann J, Boegel S, Schrörs B, Vascotto F, Castle JC, Tadmor AD, Schoenberger SP, Huber C, Türeci Ö, Sahin U. Kreiter S, et al. Among authors: van de roemer n. Nature. 2015 Jul 16;523(7560):370. doi: 10.1038/nature14567. Epub 2015 Jun 3. Nature. 2015. PMID: 26040715 No abstract available.
The global pandemic and changes in women's reproductive health: an observational study.
Haile L, van de Roemer N, Gemzell-Danielsson K, Perelló Capó J, Lete Lasa I, Vannuccini S, Koch MC, Hildebrandt T, Calaf J. Haile L, et al. Among authors: van de roemer n. Eur J Contracept Reprod Health Care. 2022 Apr;27(2):102-106. doi: 10.1080/13625187.2021.2024161. Epub 2022 Jan 18. Eur J Contracept Reprod Health Care. 2022. PMID: 35040737
The performance of a fertility tracking device.
van de Roemer N, Haile L, Koch MC. van de Roemer N, et al. Eur J Contracept Reprod Health Care. 2021 Apr;26(2):111-118. doi: 10.1080/13625187.2021.1871599. Epub 2021 Feb 8. Eur J Contracept Reprod Health Care. 2021. PMID: 33555223
Clarifications concerning the commentary "Published analysis of contraceptive effectiveness of Daysy and DaysyView app is fatally flawed".
Koch MC, Lermann J, van de Roemer N, Renner SK, Burghaus S, Hackl J, Dittrich R, Kehl S, Oppelt PG, Hildebrandt T, Hack CC, Pöhls UG, Renner SP, Thiel FC. Koch MC, et al. Among authors: van de roemer n. Reprod Health. 2019 Jun 17;16(1):83. doi: 10.1186/s12978-019-0746-1. Reprod Health. 2019. PMID: 31208442 Free PMC article. No abstract available.
Retraction Note: Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app.
Koch MC, Lermann J, van de Roemer N, Renner SK, Burghaus S, Hackl J, Dittrich R, Kehl S, Oppelt PG, Hildebrandt T, Hack CC, Pöhls UG, Renner SP, Thiel FC. Koch MC, et al. Among authors: van de roemer n. Reprod Health. 2019 May 14;16(1):54. doi: 10.1186/s12978-019-0728-3. Reprod Health. 2019. PMID: 31088503 Free PMC article.
11 results